Dawn Parsell Otto, EVP, Clinical Development at Tricida, Inc. (TCDA), sold 3,000 shares at $31.98 ($96K) on 2020-05-08, disclosed to the SEC on 2020-05-12.
Scheduled sale ($96k) by EVP, Clinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.98 | 210 | $7K | 7.0% |
| 2 | $31.98 | 523 | $17K | 17.4% |
| 3 | $31.98 | 830 | $27K | 27.7% |
| 4 | $31.98 | 1,437 | $46K | 47.9% |
| Total | $31.98 avg | 3,000 | $96K | 100% |
| Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |
| TCDA | SELL | 2020-01-06 | $227K | — | Filing → |